Menu
MENU
Menu
Menu
We then leverage our Artificial Intelligence platform to aggregate and correlate HIPAA-compliant dosing data from seed to consumption. This gives us the ability to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes.
We are a pioneering IoT device and digital care platform whose mission is to capture complex data points to better enable doctors, clinics, and end users to create highly personalized dosing regimens.
Our goal is to transform patient care through big data and AI to unearth breakthrough discoveries that will reshape our understanding of plant-based medicines.
RYAH’s easy-to-operate line of products help foster a seamless dose-control experience that generates insightful data, making it simple for doctors, researchers, and end users to hone in on the ideal settings for the best possible treatment outcomes.
